Cargando…
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
OBJECTIVE: To evaluate the possible crosstalk between C-X-C chemokine receptor 4 (CXCR4)/C-X-C motif chemokine 12 (CXCL12)/C-X-C chemokine receptor 7 (CXCR7) axis with the mammalian target of rapamycin (mTOR) pathway in neuroendocrine tumors (NETs). METHODS: Sixty-one human NETs were included into t...
Autores principales: | Circelli, Luisa, Sciammarella, Concetta, Guadagno, Elia, Tafuto, Salvatore, del Basso de Caro, Marialaura, Botti, Giovanni, Pezzullo, Luciano, Aria, Massimo, Ramundo, Valeria, Tatangelo, Fabiana, Losito, Nunzia Simona, Ieranò, Caterina, D'Alterio, Crescenzo, Izzo, Francesco, Ciliberto, Gennaro, Colao, Annamaria, Faggiano, Antongiulio, Scala, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951335/ https://www.ncbi.nlm.nih.gov/pubmed/26934559 http://dx.doi.org/10.18632/oncotarget.7738 |
Ejemplares similares
-
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015) -
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022) -
Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015) -
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019) -
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)